Cardurion Pharmaceuticals

Series-B
cardurion.com Biotech & Healthcare Burlington, United States Founded 2016 11–50 employees
Total Funding $260M
Latest Round $260M Series-B
Last Announced Jul 16, 2024
Investors 12 Backers
Decision Makers 6 Available

About Cardurion Pharmaceuticals

Transforming the treatment of cardiovascular disease and heart failure

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Burlington, United States
Year Founded 2016
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website cardurion.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $260,000,000 · Series-B

    Backed by Ascenta Capital

  2. Milestone

    Company founded

    Burlington, United States

Investors & Backers

12
Ascenta Capital
Lead
Bain Capital Life Sciences
Bain Capital Private Equity
Blue Owl Capital
Delos Capital
Digitalis Ventures
Farallon Capital Management
Fidelity
GV
Invus
Millennium Management
NEA

Funding History

1 Round
Series-B equity · Jul 16, 2024

Round backers: Ascenta Capital

Founders & Leadership

4

Elizabeth Radcliffe

Chief Financial Officer

Work email & phone locked Unlock →

Howard Surks

Chief Medical Officer and Head of Translational Medicine

Work email & phone locked Unlock →

Marcia Moore

Chief Operating Officer

Work email & phone locked Unlock →

Michael Mendelsohn

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts